Abstract:Objective: This study aims to investigate the relationship between thyroid function and prognosis in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). Methods: According to the thyroid function status of the patients at admission, they were divided into the euthyroid group (Group A), subclinical hyperthyroidism group (Group B), subclinical hypothyroidism group (Group C), and low T3 group (Group D). The clinical data of the four patient groups were compared. The logistic regression model was used to analyze the relationship between thyroid function and postoperative outcomes in patients with ACS undergoing PCI. Results: A total of 200 ACS patients who underwent PCI treatment in our hospital from January 2022 to October 2023 were selected as the research population. The incidences of subclinical hyperthyroidism, subclinical hypothyroidism, and low T3 syndrome were 17.00% (34/200), (36/200), and 29.50% (59/200), respectively. Univariate analysis of variance showed significant differences in age, diabetes, smoking history, systolic pressure and heart rate at admission, shock index, blood urea nitrogen (BUN), Cr, glucose (GLU), fibrinogen (FIB), glycosylated hemoglobin (HbA1c), creatine kinase isoenzyme (CK-MB), and CRP among all groups (p < 0.05). Thyroid function markers differed significantly across the groups (p < 0.001). Specifically, Group B exhibited the lowest thyroid stimulating hormone (TSH) levels (0.23 ± 0.09 mIU/L), whereas Group C displayed the highest (8.05 ± 3.72 mIU/L). Group D showed the lowest free triiodothyronine (FT3) levels (2.74 ± 0.51 pmol/L), and Group B had the highest free thyroxine (FT4) levels (16.31 ± 2.62 pmol/L). A significant difference in the incidences of cardiovascular death and heart failure was observed among the four groups (p < 0.05). Notably, Group D showed higher incidences of cardiovascular death (11.86%) and heart failure (50.85%). Similarly, at 1-year follow-up, a significant difference in the incidences of cardiovascular death and heart failure were found among the four groups (p < 0.05). Specially, Group D exhibited higher rates of cardiovascular death (15.25%) and heart failure (27.12%). Logistic regression analyses highlighted FT3 as a significant predictor of adverse events during hospitalization (OR = 0.335, 95% CI: 0.222–0.506, p < 0.001), while TSH emerged as an independent risk factor for adverse events during 1-year follow-up (OR = 1.136, 95% CI: 1.040–1.240, p = 0.005). Conclusion: Patients with ACS have a higher incidence of mild thyroid dysfunction. Compared with patients with euthyroid function, patients with low triiodothyronine (T3) syndrome have a worse prognosis after PCI treatment. Serum FT3 concentration and TSH can be used as predictors of poor prognosis in ACS patients.

Thyroid Function, Prevalent Coronary Heart Disease, and Severity of Coronary Atherosclerosis in Patients Undergoing Coronary Angiography

Correlation between subclinical hypothyroidism and coronary artery stenosis in patients with coronary heart disease

The correlation between thyroid function and the severity of coronary artery lesions

The Association of Thyroid Hormones with Coronary Atherosclerotic Severity in Euthyroid Patients.

The association between peripheral sensitivity of thyroid hormones and contrast-induced acute kidney injury: a retrospective study on euthyroid patients underwent coronary angiography

Relationship of thyroid stimulating hormone with coronary atherosclerosis in angina patients

Correlation of subclinical hypothyroidism with coronary heart disease and its risk factors

Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design

Association of thyroid autoimmunity with the presence and severity of coronary atherosclerosis in patients undergoing coronary angiography

Relationship among thyroid function,FT3 level and coronary artery disease in patients with coronary heart disease

Association of serum thyroid stimulating hormone levels and disease severity in coronary heart disease patients with normal thyroid function

An Assessment of Cardiac Risk Factors on Subclinical Hypothyroidism in Coronary Heart Disease Patients

Correlation between the degree of coronary artery stenosis and endothelial dysfunction in patients with coronary heart disease and subclinical hypothyroidism

Impaired Thyroid Hormone Sensitivity Increases Risk of Cardiovascular Events in Patients Undergoing Coronary Angiography

Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease

Association between Thyroid Function and Postoperative Outcomes in Patients with Acute Coronary Syndrome after Treatment with PCI: A Retrospective Study

High Thyroid-Stimulating Hormone Level is Associated with the Risk of Developing Atherosclerosis in Subclinical Hypothyroidism

The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels

Association of serum thyrotropin levels with coronary artery disease documented by quantitative coronary angiography: a transversal study

Interaction Between Triglyceride-Glucose Index and Thyroid Hormones on Coronary Artery Disease Risk in Patient with Euthyroid